Praxis Precision Medicines, Inc. PRAX Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s other commercial liabilities?
- Praxis Precision Medicines, Inc. (PRAX) reported other commercial liabilities of $17.65M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s other commercial liabilities changed year-over-year?
- Praxis Precision Medicines, Inc.'s other commercial liabilities increased by 13.5% year-over-year, from $15.55M to $17.65M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s other commercial liabilities has grown at a 26.4% compound annual growth rate (CAGR), from $10.87M to $35.03M.